Infectivity and host responses in Creutzfeldt-Jakob disease

Virology

Volumn 216, Issue 1, 1996, Pages 46-59

  Manuelidis, Laura ^a   Fritch, William ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HAMSTER; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALIA; CRICETINAE;

EID: 0029866901     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0033     Document Type: Article

References (60)

1. Akowitz, A., Sklaviadis, T., and Manuelidis, L. (1994). Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob Disease. Nucleic Acids Res. 22, 1101-1107.
2. Bolton, D., Rudelli, R., Currie, J., and Bendheim, P. (1991a). Copurification of Sp33-37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease. J. Gen. Virol. 72, 2905-2913.
3. Bolton, D. C., Seligman, S. J., Balblanian, G., Windsor, D., Scala, L. J., Kim, K. S., Chen, C. J., Kascsak, R. J., et al. (1991b). Molecular location of a species-specific epitope on the hamster scrapie agent protein. J Virol. 65, 3667-3675.
4. Brown, P., Preece, M. A., and Will, R. G. (1992). "Friendly fire" in medicine: Hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340, 24-27.
5. Brown, P., Rohwer, R. G., and Gadjusek, D. C. (1986). Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J. Infect. Dis. 153, 1145-1148.
6. Bruce, M. E., and Dickinson, A. G. (1985). Genetic control of amyloid plaque production and incubation period in scrapie-injected mice. J. Neuropathol. Exp. Neurol. 44, 285-294.
7. Bruce, M. E., and Dickinson, A. G. (1987). Biological evidence that scrapie has an independent genome. J. Gen. Virol. 68, 79-89.
8. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., Prusiner, S. B., Aguet, M., et al. (1992). Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582.
9. Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Auget, M., and Weissmann, C. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
10. SC levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19-30.
11. Campbell, I. L., Eddleston, M., Kemper, P., Oldstone, M. B. A., and Hobbs, M. V. (1994). Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68, 2383-2387.
12. Caughey, B. (1991). In vitro expression and biosynthesis of prion protein. Curr. Top. Microbiol. Immunol. 172, 93-107.
13. Caughey, B., Neary, K., Buller, R., Ernst, D., Perry, L. L., Chesebro, B., and Race, R. E. (1990). Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J. Virol. 64, 1093-1101.
14. Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., Bergstrom, S., Robbins, K., et al. (1985). Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315, 331-333.
15. Czub, M., Braig, H. R., and Diringer, H. (1988). Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis. J. Gen. Virol. 69, 1753-1756.
16. Davis, B. D., Dulbecco, R., Eisen, H. N., and Ginsberg, H. S. (1973). "Microbiology." Harper & Row, New York.
17. Dickinson, A. G., Fraser, H., and Outram, G. W. (1975). Scrapie incubation time can exceed natural lifespan. Nature (London) 356, 732-733.
18. Diedrich, J. F., Bendheim, P. E., Kim, Y. S., Carp, R. I., and Haase, A. T. (1991a). Neuropathological changes in scrapie and Alzheimer's Disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65, 4759-4768.
19. Diedrich, J. F., Bendheim, P. E., Kim, Y. S., Carp, R. I., and Haase, A. T. (1991b). Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. USA 88, 375-379.
20. Diedrich, J., Carp, R., and Haase, A. (1993). Increased expression of heat shock protein, transferrin, and B2-microglobulin in astrocytes during scrapie. Microbial Pathogen. 15, 1-6.
21. Dimitrov, D., Willey, R. L., Sato, H., Chang, L.-J., Blumenthal, R., and Martin, M. A. (1993). Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67, 2182-2190.
22. Dimitrov, D., and Martin, M. (1995). CD4+ cell turnover. Nature 375, 194-195.
23. Diringer, H., and Ehlers, B. (1991). Chemoprophylaxis of scrapie in mice. J. Gen. Virol. 72, 457-460.
24. Fields, B. N. (1987). Powerful prions. N. Engl. J. Med. 317, 1597-1598.
25. Forloni, G. F., Angeretti, N., Chiesa, R., Monzani, F., Salmona, M., Bugiani, O., and Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362, 543-546.
26. Ho, D., Neumann, A. A. P., and Chen, W. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
27. Hsiao, K. K., Groth, D., Yang, S.-L., Serban, H., Rapp, D., Foster, D., Scott, M., Torchia, M., et al. (1994). Transgenic mice which express mutant prion protein transmit neurological disease to rodents. N. Y. Acad. Sci. 724, 241-245.
28. Hsiao, K. K., Scott, M., Foster, D., Groth, D. F., DeArmond, S. J., and Prusiner, S. B. (1990). Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250, 1587-1590.
29. Hunter, G. D., Kimberlin, R. H., and Millson, G. C. (1972). Absence of eclipse phase in scrapie mice. Nature (London) 235, 31-32.
30. Jendroska, K., Heinzel, F. P.,Torchia, D.,and Stowring, L. (1991). Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 41, 1482-1490.
31. Kim, J. H., Manuelidis, L., and Manuelidis, E. E. (1988). Cerebral glycosidases in experimental Creutzfeldt-Jakob disease. J. Neurol. Sci. 84, 95-100.
32. Kimberlin, R. H., and Walker, C. A. (1986). Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 67, 255-263.
33. Laszlo, L., Lowe, J., Self, T., Kenwards, N., Landon, M., McBride, T., Farquhar, C., McConnell, I., et al. (1992). Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J. Pathol. 166, 333-341.
34. Manuelidis, E. E., Angelo, J., Kim, J., and Manuelidis, L. (1976). Serial propagation of Creutzfeldt-Jakob disease in guinea pigs. Proc. Natl. Acad. Sci. USA 73, 223-227.
35. Manuelidis, E. E., Gorgacz, E. J., and Manuelidis, L. (1978a). Transmission of Creutzfeldt-Jakob disease to mice with scrapie-like syndromes. Nature 271, 778-779.
36. Manuelidis, E. E., Gorgacz, E. J., and Manuelidis, L. (1978b). Interspecies transmission of Creutzfeldt-Jakob disease to Syrian hamsters with reference to clinical syndromes and strains of agent. Proc. Natl. Acad. Sci. USA 75, 3432-3436.
37. Manuelidis, E. E., Gorgacz, E. J., and Manuelidis, L. (1978c). Viremia in experimental Creutzfeldt-Jakob disease. Science 200, 1069-1071.
38. Manuelidis, E. E., and Manuelidis, L. (1979). Experiments on maternal transmission of Creutzfeldt-Jakob disease in guinea pigs. Proc. Soc. Exp. Biol. Med. 160, 233-236.
39. Manuelidis, E. E., Kim, J. H., and Manuelidis, L. (1983). Novel biological properties of Creutzfeldt-Jakob infected brains in vitro. Banbury Rep. (Cold Spring Harbor), 15, 412-424.
40. Manuelidis, E. E., Fritch, W. W., Kim, J. H., and Manuelidis, L. (1987). Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent. Proc. Natl. Acad. Sci. USA 84, 871-875.
41. Manuelidis, L. (1994a). Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies. Ann. N. Y. Acad. Sci. 724, 259-281.
42. Manuelidis, L. (1994b). The dimensions of Creutzfeldt-Jakob Disease. Transfusion 34, 915-928.
43. Manuelidis, L., Valley, S., and Manuelidis, E. E. (1985). Specific proteins in Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants. Proc. Natl. Acad. Sci. USA 82, 4263-4267.
44. Manuelidis, L., and Manuelidis, E. E. (1985). Recent developments in scrapie and Creutzfeldt-Jakob disease. Prog. Med. Virol. 33, 78-98.
45. Manuelidis, L., Sklaviadis, T., and Manuelidis, E. E. (1987a). Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J. 6, 341-347.
46. Manuelidis, L., Tesin, D. M., Sklaviadis, T., and Manuelidis, E. E. (1987b). Astrocyte gene expression in Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 84, 5937-5941.
47. Manuelidis, L., Murdoch, G., and Manuelidis, E. E. (1988). Potential involvement of retroviral elements in human dementias. Ciba Found. Symp. 135, 117-134.
48. Manuelidis, L., Sklaviadis, T., Akowitz, A., and Fritch, W. (1995). Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 92, 5124-5128.
49. McBride, P. A., Eikelenbloom, P., Kraal, G., Fraser, H., and Bruce, M. E. (1992). PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J. Pathol. 168, 413-418.
50. McKinley, M. P., Bolton, D. C., and Prusiner, S. B. (1983). A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62.
51. McKinley, M. P., Taraboulos, A., Kenaga, L., Serban, D., Stieber, A., DeArmond, S. J., Prusiner, S. B., and Gonatas, N. (1991). Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab. Invest. 65, 622-630.
52. Meyer, R. K., McKinley, M. P., Bowman, K. A., Braunfeld, M. B., Barry, R. A., and Prusiner, S. B. (1986). Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 83, 2310-2314.
53. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and K., I. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
54. Oesch, B. D., Westaway, D., Wälchi, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., et al. (1985). A cellular gene encodes scrapie PrP 27-30 Protein. Cell 40, 735-746.
55. Prusiner, S. B. (1991). Molecular biology of prion diseases. Science 252, 1515-1522.
56. Rubenstein, R., Merz, P. A., Kascsak, R., Scalici, C., Papini, M. C., Carp, R. I., and Kimberlin, R. H. (1991). Scrapie-infected spleens: Analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins. J. Infect. Dis. 164, 29-35.
57. Selvaggini, C., DeGioia, L., Cantu, L., Ghibaudi, E., Diomede, L., Passerini, F., Forloni, G., Bugiani, O., et al. (1993). Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Acta 194, 1380-1386.
58. Sklaviadis, T., Manuelidis, L., and Manuelidis, E. E. (1986). Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie. Proc. Natl. Acad. Sci. USA 83, 6146-6150.
59. Taraboulos, A., Serban, D., and Prusiner, S. B. (1990). Scrapie prion proteins accumulate in the cytoplasm of persistently-infected cultured cells. J. Cell Biol. 110, 2117-2132.
60. Xi, Y. G., Ingrosso, A., Ladogana, A., Masullo, C., and Pocchiari, M. (1992). Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356, 598-601.